Enochian Biosciences Executive Vice Chair Mark Dybul's 2020 pay falls 33% to $1.3M
Enochian Biosciences reports 2020 executive compensation
By ExecPay News
Published: February 3, 2021
Enochian Biosciences reported fiscal year 2020 executive compensation information on February 3, 2021.
In 2020, two executives at Enochian Biosciences received on average a compensation package of $771K, a 7% increase compared to previous year.
Average pay of disclosed executives at Enochian Biosciences
Mark Dybul, Executive Vice Chair, received $1.3M in total, which decreased by 33% compared to 2019. 66% of Dybul's compensation, or $833K, was in option awards. Dybul also received $430K in salary.
Luisa Puche, Chief Financial Officer, received a compensation package of $280K, which decreased by 45% compared to previous year. 71% of the compensation package, or $200K, was in salary.
Enochian Biosciences' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on February 3, 2021.